RESEARCH TRIANGLE PARK, N.C., March 10, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today reported its financial results for the ...

Fennec Pharmaceuticals shares were down after the company reported fourth-quarter results. The stock was recently down 10% to $6.20 and is down about 2% this year. Revenue declined to $7.93 ...

Milestone Marks an Important Step in Achieving Fennec’s Mission of Expanding Access to PEDMARQSI to Cancer Patients Across the Globe at Risk of Hearing Loss ~ RESEARCH TRIANGLE PARK, N.C., Feb. 07, ...

Weighing in at around 1kg, the fennec fox is the smallest of all the foxes. As a resident across the Sahara desert and other parts of North Africa the fennec’s long hairs may seem a bit out of ...

FENNEC PHARMACEUTICALS ($FENC) posted quarterly earnings results on Monday, March 10th. The company reported earnings of -$0.06 per share, missing estimates of $0.17 ...